Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance

NCT00422006 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT00422006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00422006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2008
Completion date
November 30, 2013
Enrollment
111 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity